Deregulations of miR‐1 and its target Multiplexin promote dilated cardiomyopathy associated with myotonic dystrophy type 1
EMBO reports · 2023
DOI: 10.15252/embr.202256616 ↗Kurz gefasst
Fachartikel in der Zeitschrift EMBO reports, 2023. Verfasst von Anissa Souidi und 5 weiteren Autor:innen. Beteiligte Einrichtung: iGReD Genetics Reproduction and Development Institute, Clermont Auvergne University, Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Myotonic Dystrophy, Cardiomyopathy, Dilated, MicroRNAs. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center of Neurology and Psychiatry.
Abstract (Originalsprache)
Myotonic dystrophy type 1 (DM1) is the most common muscular dystrophy in adults. It is caused by the excessive expansion of noncoding CTG repeats, which when transcribed affects the functions of RNA‐binding factors with adverse effects on alternative splicing, processing, and stability of a large set of muscular and cardiac transcripts. Among these effects, inefficient processing and down‐regulation of muscle‐ and heart‐specific miRNA, miR‐1 , have been reported in DM1 patients, but the impact of reduced miR‐1 on DM1 pathogenesis has been unknown. Here, we use Drosophila DM1 models to explore the role of miR‐1 in cardiac dysfunction in DM1. We show that miR‐1 down‐regulation in the heart leads to dilated cardiomyopathy (DCM), a DM1‐associated phenotype. We combined in silico screening for miR‐1 targets with transcriptional profiling of DM1 cardiac cells to identify miR‐1 target genes with potential roles in DCM. We identify Multiplexin (Mp) as a new cardiac miR‐1 target involved in DM1. Mp encodes a collagen protein involved in cardiac tube formation in Drosophila . Mp and its human ortholog Col15A1 are both highly enriched in cardiac cells of DCM‐developing DM1 flies and in heart samples from DM1 patients with DCM, respectively. When overexpressed in the heart, Mp induces DCM, whereas its attenuation rescues the DCM phenotype of aged DM1 flies. Reduced levels of miR‐1 and consecutive up‐regulation of its target Mp/Col15A1 might be critical in DM1‐associated DCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- iGReD Genetics Reproduction and Development Institute, Clermont Auvergne University, Clermont-Ferrand, France.
- Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan.
ORCID-Profile: Monika Zmojdzian, Teresa Jagla, Krzysztof Jagla
Förderung
- National Center of Neurology and Psychiatry
Zitieren
APA
Souidi, A., Nakamori, M., Zmojdzian, M., Jagla, T., Renaud, Y., & Jagla, K. (2023). Deregulations of miR‐1 and its target Multiplexin promote dilated cardiomyopathy associated with myotonic dystrophy type 1. EMBO reports. https://doi.org/10.15252/embr.202256616
Vancouver
Souidi A, Nakamori M, Zmojdzian M, Jagla T, Renaud Y, Jagla K. Deregulations of miR‐1 and its target Multiplexin promote dilated cardiomyopathy associated with myotonic dystrophy type 1. EMBO reports. 2023. doi:10.15252/embr.202256616
BibTeX
@article{Souidi2023,
author = {Souidi, Anissa and Nakamori, Masayuki and Zmojdzian, Monika and Jagla, Teresa and Renaud, Yoan and Jagla, Krzysztof},
title = {Deregulations of miR‐1 and its target Multiplexin promote dilated cardiomyopathy associated with myotonic dystrophy type 1},
journal = {EMBO reports},
year = {2023},
doi = {10.15252/embr.202256616}
}
EUVIMED